{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:49Z","timestamp":1790899249822,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.bbi.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T04:31:34Z","timestamp":1507955494000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy"],"prefix":"10.1016","volume":"72","author":[{"given":"Teresa","family":"Ravizza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Balosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2017.10.008_b0005","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1089\/ars.2013.5349","article-title":"Disulfide-containing High Mobility Group Box-1 promotes N-methyl-d-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons","volume":"21","author":"Balosso","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbi.2017.10.008_b0010","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1212\/WNL.0b013e31822f04a0","article-title":"Circumventricular organs: receptive and homeostatic functions and clinical implications","volume":"77","author":"Benarroch","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2017.10.008_b0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.1008585","article-title":"HMGB1 loves company","volume":"86","author":"Bianchi","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2017.10.008_b0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1474-4422(12)70018-2","article-title":"Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial","volume":"11","author":"Bonnett","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2017.10.008_b0025","doi-asserted-by":"crossref","first-page":"e0140918","DOI":"10.1371\/journal.pone.0140918","article-title":"HMGB1 contributes to the expression of P-glycoprotein in mouse epileptic brain through toll-like receptor 4 and receptor for advanced glycation end products","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2017.10.008_b0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbi.2015.12.012","article-title":"Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior","volume":"53","author":"Cheng","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2017.10.008_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fncel.2014.00155","article-title":"The inflammatory molecules IL-1\u03b2 and HMGB1 can rapidly enhance focal seizure generation in a brain slice model of temporal lobe epilepsy","volume":"8","author":"Chiavegato","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2017.10.008_b0040","doi-asserted-by":"crossref","first-page":"8672","DOI":"10.1523\/JNEUROSCI.4806-13.2014","article-title":"A novel, noninvasive, predictive epilepsy biomarker with clinical potential","volume":"34","author":"Choy","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.10.008_b0045","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1523\/JNEUROSCI.6676-10.2011","article-title":"Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice","volume":"31","author":"Costello","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.10.008_b0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","article-title":"Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury","volume":"34","author":"de Rivero Vaccari","year":"2014","journal-title":"J Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbi.2017.10.008_b0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuropharm.2015.11.001","article-title":"ATPergic signalling during seizures and epilepsy","volume":"104","author":"Engel","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2017.10.008_b0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbi.2017.10.008_b0065","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41598-017-01325-y","article-title":"Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice","volume":"7","author":"Fu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2017.10.008_b0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuron.2015.05.019","article-title":"Dealing with danger in the CNS: the response of the immune system to injury","volume":"87","author":"Gadani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2017.10.008_b0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.bbi.2017.10.008_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1101\/lm.2.1.26","article-title":"Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice","volume":"2","author":"Gerlai","year":"1995","journal-title":"Learn Mem"},{"key":"10.1016\/j.bbi.2017.10.008_b0085","doi-asserted-by":"crossref","first-page":"e89450","DOI":"10.1371\/journal.pone.0089450","article-title":"Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia\/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats","volume":"9","author":"Gong","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bbi.2017.10.008_b0090","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/epi.13688","article-title":"Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice","volume":"58","author":"Gross","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbi.2017.10.008_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2017.10.008_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(01)01075-5","article-title":"Lipopolysaccharide inhibits induction of long-term potentiation and depression in the rat hippocampal CA1 area","volume":"422","author":"Jo","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2017.10.008_b0105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000460513","article-title":"Extracellular HMGB1 Modulates glutamate metabolism associated with kainic acid-induced epilepsy-like hyperactivity in primary rat neural cells","volume":"41","author":"Kaneko","year":"2017","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bbi.2017.10.008_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","article-title":"HMGB1 in health and disease","volume":"40","author":"Kang","year":"2014","journal-title":"Mol. Aspects of Med."},{"key":"10.1016\/j.bbi.2017.10.008_b0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(06)70383-0","article-title":"Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial","volume":"5","author":"Kim","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2017.10.008_b0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/14737175.6.3.397","article-title":"Refractory epilepsy: mechanisms and solutions","volume":"6","author":"Kwan","year":"2006","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.bbi.2017.10.008_b0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cmdc.201500188","article-title":"Therapeutic developments targeting toll-like receptor-4-mediated neuroinflammation","volume":"11","author":"Li","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbi.2017.10.008_b0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.nbd.2014.11.021","article-title":"Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury","volume":"74","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2017.10.008_b0135","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats","volume":"21","author":"Liu","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbi.2017.10.008_b0140","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.1316925111","article-title":"JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2017.10.008_b0145","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nature11290","article-title":"Novel role of PKR in inflammasome activation and HMGB1 release","volume":"488","author":"Lu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2017.10.008_b0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13238-012-2118-2","article-title":"Regulation of HMGB1 release by inflammasomes","volume":"4","author":"Lu","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbi.2017.10.008_b0155","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/1744666X.2014.909730","article-title":"Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review","volume":"10","author":"Lu","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.bbi.2017.10.008_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eplepsyres.2016.03.005","article-title":"Upregulation of HMGB1, toll-like receptor and RAGE in human Rasmussen's encephalitis","volume":"123","author":"Luan","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bbi.2017.10.008_b0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2017.10.008_b0170","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2017.10.008_b0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2011.08.012","article-title":"High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products","volume":"232","author":"Mazarati","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2017.10.008_b0180","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.1523\/JNEUROSCI.2435-08.2008","article-title":"The HMGB1 receptor RAGE mediates ischemic brain damage","volume":"28","author":"Muhammad","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.10.008_b0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10799893.2014.984309","article-title":"Role of high-mobility group box-1 protein in disruption of vascular barriers and regulation of leukocyte-endothelial interactions","volume":"35","author":"Nawaz","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.bbi.2017.10.008_b0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/02699052.2016.1217045","article-title":"The danger zone: systematic review of the role of HMGB1 danger signalling in traumatic brain injury","volume":"31","author":"Parker","year":"2017","journal-title":"Brain Injury"},{"key":"10.1016\/j.bbi.2017.10.008_b0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nbd.2016.05.001","article-title":"Cognitive deficits and brain myo-Inositol are early biomarkers of epileptogenesis in a rat model of epilepsy","volume":"93","author":"Pascente","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bbi.2017.10.008_b0200","article-title":"Rapid, coordinate inflammatory responses after experimental febrile status epilepticus: implications for epileptogenesis","volume":"9","author":"Patterson","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.bbi.2017.10.008_b0205","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/brain\/awx117","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"140","author":"Pauletti","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2017.10.008_b0210","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Pitk\u00e4nen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbi.2017.10.008_b0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(15)00248-3","article-title":"Development of epilepsy after ischaemic stroke","volume":"15","author":"Pitk\u00e4nen","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2017.10.008_b0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/epi.13652","article-title":"WONOEP appraisal: Biomarkers of epilepsy-associated comorbidities","volume":"58","author":"Ravizza","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbi.2017.10.008_b0225","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/epi.12061","article-title":"Increased excitability and molecular changes in adult rats after a febrile seizure","volume":"54","author":"Reid","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbi.2017.10.008_b0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2741\/1241","article-title":"Signaling the brain in systemic inflammation: role of sensory circumventricular organs","volume":"9","author":"Roth","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbi.2017.10.008_b0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2013.02.002","article-title":"Mitochondrial involvement and oxidative stress in temporal lobe epilepsy","volume":"62","author":"Rowley","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbi.2017.10.008_b0240","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1523\/JNEUROSCI.3693-08.2008","article-title":"Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo","volume":"28","author":"Sakatani","year":"2008","journal-title":"J. Neurosc."},{"key":"10.1016\/j.bbi.2017.10.008_b0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2017.10.008_b0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arr.2014.11.003","article-title":"DAMPs and neurodegeneration","volume":"24","author":"Thundyil","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbi.2017.10.008_b0255","doi-asserted-by":"crossref","first-page":"4.1","DOI":"10.1146\/annurev-pharmtox-010814-124607","article-title":"Candidate drug targets for prevention or modification of epilepsy","volume":"55","author":"Varvel","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbi.2017.10.008_b0260","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2015.00422","article-title":"DAMPs from cell death to new life","volume":"6","author":"V\u00e9n\u00e9reau","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2017.10.008_b0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bbi.2017.10.008_b0270","article-title":"Immunity and inflammation in epilepsy","volume":"6","author":"Vezzani","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbi.2017.10.008_b0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2017.10.008_b0280","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1172\/JCI92001","article-title":"Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy","volume":"127","author":"Walker","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2017.10.008_b0285","doi-asserted-by":"crossref","first-page":"46243","DOI":"10.1038\/srep46243","article-title":"Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2017.10.008_b0290","first-page":"399","article-title":"The blood-brain barrier and its role in inflammation","volume":"14","author":"Webb","year":"2000","journal-title":"J. Vet. Internal Med."},{"key":"10.1016\/j.bbi.2017.10.008_b0295","doi-asserted-by":"crossref","first-page":"11621","DOI":"10.1074\/jbc.M113.449942","article-title":"Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy","volume":"288","author":"Zandarashvili","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2017.10.008_b0300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2017.10.008_b0305","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/brain\/awr032","article-title":"Activation of TLR, RAGE and HMGB1 signaling in malformations of cortical development","volume":"134","author":"Zurolo","year":"2011","journal-title":"Brain"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117304646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117304646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:49:36Z","timestamp":1760168976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117304646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":61,"alternative-id":["S0889159117304646"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.10.008","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}